Skip to content

Sleep Disordered Breathing and Lung Transplantation

Sleep Disordered Breathing and Lung Transplantation

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01179087
Enrollment
40
Registered
2010-08-11
Start date
2010-08-31
Completion date
2014-09-30
Last updated
2013-08-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung Transplantation, Sleep Disordered Breathing

Keywords

sleep disordered breathing, lung transplantation

Brief summary

The purpose of the study is to investigate the prevalence, clinical predictors and consequences (effect on survival, chronic rejection) of sleep disordered breathing in lung transplant recipients.

Detailed description

All patients with end-stage respiratory failure who are referred for lung transplantation and are older than 18 years old are enrolled. We collect: * Medical history * Blood pressure * Anthropometrics * Pulmonary function * Arterial blood gas * Questionnaire (QOL, ESS) * Sleep diary * Polysomnography

Interventions

None listed

Sponsors

KU Leuven
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* Patients with end-stage respiratory failure who are referred for lung transplantation * Informed consent from patient

Exclusion criteria

* Patients who are declined for lung transplantation * Patients \< 18 years old

Design outcomes

Primary

MeasureTime frameDescription
Prevalence of sleep disordered breathing1 month after lung transplantationPolysomnography will be performed at discharge from the hospital (1 month average)

Secondary

MeasureTime frameDescription
Pulmonary function1 year after lung transplantationEffect of SDB on pulmonary function/BOS
Investigate possible relationship between SDB and patient medical history1 year after lung transplantation

Countries

Belgium

Contacts

Primary ContactBertien MA Buyse, MD, PhD
bertien.buyse@uzleuven.be+32 16 34 68 00
Backup ContactDries Testelmans, MD, PhD
dries.testelmans@uzleuven.be+32 16 34 68 00

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026